Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137494) titled 'A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)' on Aug. 15.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Memorial Sloan Kettering Cancer Center
Condition:
Primary Central Nervous System (CNS) Lymphoma
Secondary Central Nervous System Lymphoma
Intervention:
Biological: MB-CART19.1 Cellular Therapy...
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: August 14, 2025
Target Sample Size: 12
Countries of Recru...